1. Contemporary therapy for advanced soft-tissue sarcomas in adults: a review;Pang;JAMA Oncol,2016
2. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018
3. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial;Tawbi;Lancet Oncol,2017
4. Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials;D’Angelo;Lancet Oncol,2018
5. Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART);Wagner;J Immunother Cancer,2021